About this document

FMT by publication1 is a document available to read on EtoBox.

This scoping review examines the role of fecal microbiota transplantation (FMT) in managing type 1 diabetes (T1D), highlighting its potential to restore gut microbiota balance and modulate immune responses. Preclinical studies indicate that FMT can delay diabetes onset and improve metabolic outcomes, while early clinical trials show promise in reducing inflammation and improving glycemic control. However, challenges such as microbiome heterogeneity and safety concerns must be addressed to optimize FMT

Author

publication1

Language

EN